
|Articles|April 7, 2023
Pharma USA 2023: Changes to the Medical Affairs Function
Sunil Verma, SVP, Global Head of Oncology, Medical, AstraZeneca discusses how the Medical Affairs role will become more strategic and effective with data.
Advertisement
Sunil Verma, MD, SVP, Global Head of Oncology, Medical, AstraZeneca recently presented at Pharma USA 2023 on the topic, "The beginning of a new Medical, the end of an Affair." In this video, Dr. Verma tells PharmExec about how the role of medical affairs will positively influence patient outcomes and the standard of care with the use of data.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
2026 Pharm Exec Top 50 Companies
2
M&A Roundup: LEO Pharma Acquires Dersimelagon, BioMarin Acquires Alesta, OmniAb Enters collaboration with Eli Lilly, Chugai and GSK Enter License Agreement for AID351
3
Who Pays for Tariff Driven Input Cost Increases?
4
Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs
5




